Hayes Christopher G.

Number of records: 9
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
19-Mar-24 4:31 PM
View: 
Verrica Pharmaceuticals Inc. (VRCA) 15-Mar-24Grant 40,000----32%
123.23K to 163.23K
16-Nov-23 4:32 PM
View: 
Verrica Pharmaceuticals Inc. (VRCA) 15-Nov-23Sale 11,558$2.97$34,327.30(9%)
134.78K to 123.23K
16-Nov-23 4:32 PM
View: 
Verrica Pharmaceuticals Inc. (VRCA) 14-Nov-23Sale 22,141$2.93$64,873.10(14%)
156.93K to 134.78K
28-Aug-23 4:39 PM
View: 
Verrica Pharmaceuticals Inc. (VRCA) 24-Aug-23Grant 75,000----92%
81.92K to 156.93K
25-Jul-23 4:25 PM
View: 
Verrica Pharmaceuticals Inc. (VRCA) 24-Jul-23Sale 33,789$4.83$163,201.00(29%)
115.71K to 81.92K
25-Jul-23 4:25 PM
View: 
Verrica Pharmaceuticals Inc. (VRCA) 21-Jul-23Grant 100,000----636%
15.71K to 115.71K
11-Jul-22 5:24 PM
View: 
Verrica Pharmaceuticals Inc. (VRCA) 11-Jul-22Private Purchase 7,500$3.40$25,500.0091%
8.21K to 15.71K
05-Jul-22 4:13 PM
View: 
Verrica Pharmaceuticals Inc. (VRCA) 05-Jul-22Private Purchase 5,714$2.10$11,999.40229%
2.5K to 8.21K
07-Jun-21 8:42 AM
View: 
Verrica Pharmaceuticals Inc. (VRCA) 04-Jun-21Market Purchase 2,500$9.79$24,475.00100%
0 to 2.5K
(< 1%)